We have identi®ed and characterized a new calcium/ calmodulin (Ca 2+ /CaM) dependent protein kinase termed death-associated protein kinase 2 (DAPK2) that contains an N-terminal protein kinase domain followed by a conserved CaM-binding domain with signi®cant homologies to those of DAP kinase, a protein kinase involved in apoptosis. DAPK2 mRNA is expressed abundantly in heart, lung and skeletal muscle. The mapping results indicated that DAPK2 is located in the central region of mouse chromosome 9. In vitro kinase assay revealed that DAPK2 is autophosphorylated and phosphorylates myosin light chain (MLC) as an exogenous substrate. DAPK2 binds directly to CaM and is activated in a Ca 2+ /CaM-dependent manner. A constitutively active DAPK2 mutant is generated by removal of the CaMbinding domain (DCaM). Treatment of agonists that elevate intracellular Ca 2+ -concentration led to the activation of DAPK2 and transfection studies revealed that DAPK2 is localized in the cytoplasm. Overexpression of DAPK2, but not the kinase negative mutant, signi®cantly induced the morphological changes characteristic of apoptosis. These results indicate that DAPK2 is an additional member of DAP kinase family involved in apoptotic signaling.
Introduction
Apoptosis, an essential mechanism for normal development and maintainence of tissue homeostasis, can be induced in response to a variety of stimuli including cytokines, growth factor withdrawal and stresses (White, 1996; Steller, 1995) . Cells undergoing apoptosis exhibit biochemical and morphological changes including membrane blebbing, cell shrinkage, genomic DNA fragmentation, elevation of cytoplasmic Ca 2+ concentration and formation of an apoptotic body. Increasing number of essential molecules that participate in these events have been identi®ed. Critical and widely used molecules that play a central role in the apoptotic pathway are a caspase family of cystaine proteases that are related to the C. elegans cell death gene ced-3 (Yuan et al., 1993; Nagata, 1997; Thornberry and Lazebnik, 1998) . Mutant mice lacking the caspase family member revealed its essential role for execution of apoptosis in vivo (Kuida et al., 1996 (Kuida et al., , 1998 Hakem et al., 1998) . In addition to the activation of caspases, apoptosis is known to be mediated by activation of c-Myc, p53 and protein kinases (Askew et al., 1991; Evan et al., 1992; Lowe et al., 1993; Anderson, 1997) . Evidence has been presented that certain protein kinases have an ability to induce apoptosis, or are activated by various apoptotic stimuli. Activation of cyclin dependent-protein kinase (CDK), Cdc2 kinase was correlated with apoptosis of lymphoma cells induced by granzyme B (Shi et al., 1994 ). An additional CDK, p58 PITSRLE induced apoptosis upon overexpression in Chinese hamster ovary cells and was activated by Fas-stimulation (Lahti et al., 1995) . FAST and RICK (also known as RIP2) kinases are also implicated in Fas-mediated apoptosis (Tian et al., 1995; Inohara et al., 1998; McCarthy et al., 1998) . Various apoptotic stimuli such as Fas, TNF-a, ceramide and stresses induce activation of c-Jun N-terminal kinase (JNK), also known as stress activated protein kinase (SAPK) (Hibi et al., 1993; Derijard et al., 1994; Verheij et al., 1996; Xia et al., 1995) . This suggests the involvement of the JNK pathway in the apoptotic signaling. Indeed, upstream kinases of JNKs, MEKK1 and ASK1, and downstream target c-Jun were reported to induce apoptosis of target cells (Ichijo et al., 1997; Lassignal Johnson et al., 1996; Cardone et al., 1997; Widmann et al., 1998; Bossy-Wetzel et al., 1997) . Activation of the calcium/ calmodulin (Ca 2+ /CaM) dependent protein kinase (CaMK) family was also shown to mediate apoptosis in some cells. CaMKII is a multifunctional protein kinase that is expressed in various tissues, and is activated by apoptotic stimuli including tumor necrosis factor (TNF) -a and UV-irradiation at doses sucient for induction of apoptosis (Wright et al., 1997) . Furthermore, selective inhibitors of CaMKII significantly inhibited apoptosis induced by such stimuli.
DAP kinase is a member of the CaMK family that was originally identi®ed as an essential molecule in interferon (IFN) -g-induced apoptosis in HeLa cells (Deiss et al., 1995; Cohen et al., 1997) . It was shown that the reduced expression of DAP kinase mediated by antisense mRNA protected HeLa cells from apoptosis induced by IFN-g, and overexpression of DAP kinase induced apoptosis . DAP kinase has been reported to function as a possible tumor suppressor gene (Kissil et al., 1997; Inbal et al., 1997) . Recently, ZIP kinase has been identi®ed by the yeast two-hybrid screening in which the leucine zipper domain of ATF4, a member of Activating Transcription Factor/ cAMP responsive element binding protein (ATF/CREB) family of transcriptional factor was used as a bait . The catalytic domain of ZIP kinase shares a strong similarity to that of DAP kinase. Ectopic expression of ZIP kinase also induced the morphological changes of apoptosis in NIH3T3 cells. It was shown that the catalytic activities of both DAP-and ZIP-kinases were required for the induction of apoptosis. Recently, we have identi®ed two novel /CaM binding domains between DAPK2 and DAP kinase. Amino acid residues conserved between two molecules are highlighted with solid boxes. (d) Amino acid identities of the catalytic domains of DAP kinase (DAPK), DAPK2, ZIP kinase (ZIPK), DRAK1 and DRAK2. (e) Unrooted phylogenic tree of the kinase domains of the DAP kinase family. The Clustal W program was used to align the kinase domains of the DAP kinase family. The unrooted phylogenic tree was constructed by the DRAWTREE program (Thompson et al., 1994) . protein kinases termed DAP kinase related apoptosisinducing kinase (DRAK)1 and DRAK2, both of which also show homology to DAP-and ZIP-kinases in their catalytic domains . Overexpression of DRAKs but not the kinase negative mutants also induced the morphological changes of apoptosis in NIH3T3 cells. Collectively, these kinases represent a new family of protein kinase whose catalytic activity is sucient for induction of apoptosis. However, to date, the precise mechanisms by which these kinases mediate apoptosis are unclear.
In this report, we have identi®ed a novel protein kinase designated DAP kinase 2 (DAPK2). DAPK2 contains an N-terminal protein kinase domain followed by a region homologous to the Ca 2+ /CaM binding domain, both of which share homology with those of DAP kinase. Overexpression of DAPK2, but not the kinase negative mutant induced the morphological changes of apoptosis in 293 and NIH3T3 cells. These results indicate that DAPK2 is a new member of DAP kinase family involved in apoptosis.
Results

cDNA cloning and structure of human and mouse DAPK2
To obtain cDNAs with signi®cant similarity to DAP kinase, we searched for EST clones in the DDBJ, EMBL and GenBank databases with the nucleotide sequence of the catalytic domain of human DAP kinase as the query. A search using the BLAST program revealed that two EST clones with the accession numbers AA858002 (human) and W82116 (mouse) showed a high degree of homology to the catalytic domain of DAP kinase. On the basis of the reported sequences of these clones, we performed the RACE protocols with the corresponding primers to isolate full length cDNAs from human skeletal muscle and mouse lung cDNA libraries. Considering the sequence similarity, we designated this novel molecule DAP kinase 2 (DAPK2). Predicted amino acid sequences of both human and mouse DAPK2 are shown in Figure 1a . Both DAPK2 contain an open reading frame of 1110 bp and were predicted to encode a protein of 370 amino acid residues with a calculated molecular weight of 42.897 kDa (human) and 42.768 kDa (mouse). The N-terminal end of DAPK2 demonstrated a signi®cant homology to the catalytic domain of DAP kinase that began with amino acid 23 and extended to 285, and shared 80.2% sequence identity in the protein kinase domain (Figure 1b) . Recently, we have identi®ed ZIP kinase, DRAK1 and DRAK2 that also show signi®cant sequence similarities to DAP kinase in the catalytic domains Sanjo et al., 1998) . Additionally, the protein kinase domain of DAPK2 showed homology to ZIP kinase, DRAK1 and DRAK2 with 80.6, 46.4 and 48.3% identities, respectively (Figure 1b and d) . Based on the sequence similarity and their biological functions, we propose that these new kinases represent a new family, which we designate as the DAP kinase family. The amino acid identities and dendrogram of the catalytic domains of the DAP kinase family were shown in Figure 1d and e. In addition to the catalytic domain, it was found that DAPK2 also shared homology with DAP kinase but not ZIP kinase, DRAK1 and DRAK2 just downstream from the kinase domain (31.4% identity) (Figure 1c ). It was reported that there is a conserved CaM binding domain in this region of DAP kinase. Therefore, it is suggested that DAPK2 is also regulated by CaM through the corresponding region as in the case of DAP kinase or other Ca 2+ /CaM kinases. Unlike DAP kinase, no ankyrin repeats or death domain was found in the C-terminal region of DAPK2 (Figure 1f ). The Cterminal region of DAPK2 showed no homology to any other proteins or other known domains. The structure of the DAP kinase family member is shown in Figure 1f .
Tissue distribution of human DAPK2 mRNA
We carried out the multiple tissue Northern blot to investigate the tissue distribution of human DAPK2. As shown in Figure 2 , three major transcripts approximately the size of 6.0, 3.2 and 2.0 kb were detected in all tissues tested with strong hybridizing signals in heart, lung and skeletal muscle. The shortest transcript detected at 2.0 kb matched the obtained cDNA clone. The other transcripts were thought to be isoforms generated by alternative splicing or the transcripts encoding highly homologous proteins.
In vitro kinase activity of DAPK2
To investigate the biochemical function and the regulation of DAPK2, we carried out in vitro kinase Figure 2 Tissue distribution of DAPK2. Full length cDNA of human DAPK2 was used to probe human Multiple Tissue Northern blot containing 2 mg of poly (A) + RNA isolated from various tissues Apoptosis inducing kinase T Kawai et al assay for DAPK2. To express DAPK2 into mammalian cells, the N-terminal Flag epitope-tagged wild type (WT) DAPK2 was constructed into the pEF-BOS expression vector. We also prepared two versions of the mutant DAPK2; a mutant in which the lysine residue at amino acid 52 that is predicted to the ATPbinding site was mutated to alanine (Flag-DAPK2 K52A) and a mutant missing the region corresponding to the CaM-binding domain of DAP kinase (aa 299 ± 330) (Flag-DAPK2 DCaM). Human embryonic kidney 293 cells were transiently transfected with Flag-DAPK2 WT, K52A and DCaM. Cell lysates were prepared and immunoprecipitated with anti-Flag M2 monoclonal antibody. Kinase activity in the immunoprecipitant was measured by in vitro kinase assay. As shown in Figure 3 , the phosphorylation of Flag-DAPK2 WT protein, but not K52A mutant, was detected at 42 kDa as expected, indicating that DAPK2 acts as a protein kinase and the band found in WT is a result from autophosphorylation of DAPK2. The fact that the catalytic domain of DAPK2 shares a signi®cant homology to that of DAP kinase allowed us to investigate whether myosin light chain (MLC) is a potential exogeneous substrate because DAPK2 and DAP kinase showed homology to MLCK and DAP kinase was reported to substrate MLC in vitro . As shown in Figure 3 , DAPK2 WT phosphorylated the MLC in vitro. In contrast, DAPK2 K52A mutant failed to phosphorylate MLC. The kinase activity of DAPK2 DCaM was also con®rmed by the in vitro kinase assay. The level of MLCphosphorylation was increased when compared to WT. Furthermore, the autophosphorylation of the DCaM mutant was decreased when compared with that obtained in the WT transfection. It is possible that DAPK2 may be negatively regulated by phosphorylation at the residue(s) present in the predicted CaMbinding domain. These results are in accord with the case of DAP kinase, as well as other Ca 2+ /CaM protein kinases . Figure 4 shows the amounts of proteins expressed by Western blot analysis of the same lysates with anti-Flag antibody.
DAPK2 is a Ca
To rule out the possibility that DAPK2 is regulated by other Ca 2+ /CaM-regulatory molecules through indirect mechanisms, we tested the ability of recombinant CaM to bind directly to DAPK2. COS-7 cells were transiently transfected with Flag-DAPK2 WT and DCaM. The whole cell lysates were dissolved by SDS ± PAGE and transferred onto a nitrocellulose membrane. The membrane was incubated with recombinant-CaM in the presence of Ca 
Calcium signals activate DAPK2
The presence of the Ca 2+ /CaM-binding domain suggests the regulation of DAPK2 activity by intracellular Ca 2+ -concentration. We investigated the eect of Ca 2+ on activation of DAPK2. Human 293 cells were transiently transfected with Flag-DAPK2 WT, K52A or DCaM. Twenty-four hours after transfection, the cells were treated with 10 mM of Ca 2+ -ionophore (A23187) and 1.0 mM of Ionomycin, well-known reagents that elevate the intracellular Ca 2+ concentration, for 5 or 10 min followed by measurement of the activity of DAPK2 by in vitro kinase assay with MLC as the substrate. We also stimulated the cells with 10 mM of Thapsigargin, a reagent that produces an intracellular calcium signal by inhibiting endoplasmic reticular Ca 2+ -ATPase. As shown in Figure 5 , treatment with A23187, Ionomycin or Thapsigargin resulted in increased phosphorylation of MLC in the Flag-DAPK2 WT transfected cells. In contrast, both auto-and MLC-phosphorylations were not observed in cells expressing DAPK2 K52A. Furthermore, activity of DAPK2 DCaM showed no change after treatment with these reagents, indicating that the predicted CaM-binding domain is responsible for Ca 2+ induced-activation of DAPK2 and suggesting that Ca 2+ /CaM directly activates DAPK2 through the relief of intrinsic auto-inhibition domain present in the CaM-binding domain.
Cellular localization of Flag-DAPK2
Previously, DAP kinase was reported to be associated with cytoskeleton, whereas ZIP kinase, DRAK1 and DRAK2 were localized to the nuclei Kawai et al., 1998; Sanjo et al., 1998) . We investigated the subcellular localization of DAPK2. The expression plasmid for Flag-DAPK2 WT was transiently transfected into COS-7 cells. Twenty-four hours after transfection, the subcellular localization was determined by indirect-immunostaining with antiFlag antibody. It was found that the Flag-DAPK2 WT protein localized exclusively in the cytoplasm ( Figure  6 ).
Overexpression of DAPK2 induced the morphological changes of apoptosis
Previously, overexpression of DAP kinase, ZIP kinase, DRAK1 or DRAK2 was reported to induce the morphological changes of apoptosis in mammalian cells Kawai et al., 1998; . We investigated the ability of DAPK2 to induce apoptosis upon overexpression as in the case of these kinases. Human 293 cells were transiently cotransfected with Flag-tagged DAPK2 WT, K52A and DCaM along with the LacZ expression vector (pEF-BOS LacZ) which was used as an indicator. After 36 h, the cells were ®xed and stained with a 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal) solution to visualize the transfected cells. As shown in Figure 7a , blue cells transfected with DAPK2 DCaM showed the morphological changes typical of apoptosis characterized by membrane blebbing and shrunken cell size (54.7%). In contrast, overexpression of the kinase negative mutant (K52A) resulted in normal morphology (2.3%) at approximately the same level as the vector transfected (1.0%) (Figure 7b ). The ratio of the apoptotic cells transfected with DAPK2 WT was slightly decreased as compared with the DCaM mutant (28.3%). We also examined the ability of DAPK2 to induce apoptosis in NIH3T3 cells. As in the case of 293 cells, the morphological changes of apoptosis were induced in NIH3T3 cells expressing DAPK2 WT (27.7%) and DCaM (60.3%) but not K52A (3.0%) and the vector transfected (1.0%) (Figure 7a and b) . The phenotypes and the ratio of the apoptotic cells were similar comparing NIH3T3 and 293 cells.
To further investigate, we examined whether the nuclei condensed upon overexpression of DAPK2. NIH3T3 cells were transiently transfected with Flag-DAPK2 DCaM. After 36 h, cells were ®xed and doubly stained with anti-Flag antibody and 4,6-diamidino-2-phenylinodole (DAPI) as an indicator of the nuclei. As shown in Figure 7c , the nuclei signi®cantly condensed in cells expressing DCaM. These results indicate that the apoptotic changes also occurred in the nuclei, that DAPK2 is a potent mediator of apoptosis and the induction of apoptosis was correlated to the kinase activity of DAPK2.
DAPK2 maps in the central region of mouse chromosome 9
The mouse chromosomal location of DAPK2 was determined by interspeci®c backcross analysis using progeny derived from matings of [(C57BL/6J x Mus spretus) F1 X C57BL/6J] mice. This interspeci®c backcross mapping panel has been typed for over 2700 loci that are well distributed among all the autosomes as well as the X chromosome (Copeland and Jenkins, 1991) . C57BL/6J and M. spretus DNAs were digested with several enzymes and analysed by Southern blot hybridization for informative restriction fragment length polymorphisms (RFLPs) using a mouse DAPK2 cDNA probe. The 9.1 kb HindIII M. spretus RFLP (see Materials and methods) was used to follow the segregation of the DAPK2 locus in backcross mice. The mapping results indicated that DAPK2 is located in the central region of mouse chromosome 9 linked to Atm, Csk, and Rora. Although 152 mice were analysed for every marker and are shown in the segregation analysis (Figure 8 ), up to 181 mice were typed for some pairs of markers. Each locus was analysed in pairwise combinations for recombination frequencies using the additional data. The ratios of the total number of mice exhibiting recombinant chromosomes to the total number of mice analysed for each pair of loci and the most likely gene order are: centromere-Atm-2/181-Csk-6/158-DAPK2-2/ 164-Rora. The recombination frequencies [expressed as genetic distances in centiMorgans (cM)+the standard error] are-Atm-1.1+/70.8-Csk-3.8+/71.5-DAPK2-1.2+/70.9-Rora.
Discussion
Protein kinases are known to regulate various cellular events such as cell growth, dierentiation and apoptosis. In this report, we have identi®ed DAPK2 as a new Ca 2+ /CaM dependent protein kinase that is involved in apoptotic signaling. DAPK2 contains the N-terminal protein kinase domain with signi®cant homology to those of DAP kinase, ZIP kinase, DRAK1 and DRAK2. Just downstream to the catalytic domain, DAPK2 contains the conserved domain sharing homology to the CaM-binding domain of DAP kinase as well as to other CaM kinases. We demonstrated here that DAPK2 has an intrinsic kinase activity that phosphorylates both itself and MLC as the in vitro substrate. DAPK2 was activated by Ca 2+ /CaM through direct association and by treatment of cells with three agonists that elevate intracellular Ca
2+
. These activities were completely abolished by a point mutation in which the conserved lysine residue at 52nd was changed to alanine. The substitution of this conserved residue is known to block ATP-binding, resulting in a kinase negative /CaM and that the catalytic activity is crucial for mediating apoptosis. Taken together, DAPK2 may be one of key molecules for linking the cytoplasmic Ca 2+ to apoptotic execution. Future work will be required to clarify the relationship between Ca 2+ -induced activation of DAPK2 and induction of apoptosis. Recent evidence has suggested the critical link between the activation of the CaMK family and apoptosis. CaMKII is a multi-functional protein kinase that is expressed in various tissues and is activated in response to several apoptotic stimuli including TNF-a and UV-irradiation (Wright et al., 1997) . Treatment of cells with CaMKII inhibitors, protected cells from apoptosis induced by such stimuli. Activation of MLCK has been reported to be an essential mechanism for the induction of apoptotic morphological changes including membrane blebbing (Mills et al., 1998) . The MLCK inhibitors blocked the membrane blebbing induced by serum removal in PC12 cells. DAP kinase signi®cantly induced apoptosis upon overexpression and IFN-g-induced apoptosis was inhibited by transfection of the kinase negative mutant of DAP kinase . Furthermore, cells transfected with DAP kinase were more sensitive to apoptosis induced by TNF-a and the cells costimulated with TNF-a and cycloheximide resulted in faster migration of the DAP kinase protein on SDS ± PAGE, probably due to protein modi®cations such as protein phosphorylation or cleavage by proteases (Inbal et al., 1997) . These results suggest that DAP kinase may be a key signaling molecule in not only IFN-g but also TNF-a-mediated apoptosis.
Although the catalytic domains among the DAP kinase family including DAPK2, DAP kinase, ZIP kinase and DRAKs are closely related, the noncatalytic C-terminal regions are dierent. DAP kinase contains several functional motifs characterized by the N-terminal kinase domain followed by the CaMbinding domain, eight ankyrin repeats and the death domain at the C-terminal end (Feinstein et al., 1996; Cohen et al., 1997) . ZIP kinase contains the leucine zipper domain at its C-terminus in addition to the Nterminal kinase domain . These domains are known to mediate homodimerization or interacting with other proteins containing these domains. In fact, ZIP kinase was shown to interact with the bZIP transcriptional factor ATF4, and to be activated by the formation of homodimer through the leucine zipper . In the case of DRAKs, they show homology in the non-catalytic Cterminal regions (24.1%) . Deletion studies revealed that the C-terminal domains were required for regulation of the kinase activities of DRAKs, suggesting that DRAKs may be associated with a regulatory molecule(s) through these domains. However, the C-terminal domains of DRAKs show no homology to any other proteins or to the known functional domains or motifs. It is also predicted that the non-catalytic C-terminal domain of DAPK2 may also function as an interaction domain. However, homodimerization of DAPK2 was not detected by the yeast two-hybrid system (Kawai and Akira, unpublished observation).
We have compared our interspeci®c map of chromosome 9 with a composite mouse linkage map that reports the map location of many uncloned mouse mutations (provided from Mouse Genome Database, a computerized database maintained at The Jackson Laboratory, Bar Harbor, ME, USA). DAPK2 mapped in a region of the composite map that lacks mouse mutations with a phenotype that might be expected for an alteration in this locus (data now shown). The central region of mouse chromosome 9 shares regions of homology with human chromosomes 11q and 15q (summarized in Figure 8 ). In particular, Csk has been mapped to 15q23-q25 and Rora to 15q22. The placement of DAPK2 between Csk and Rora in mouse suggests that the human homolog of DAPK2 will map to 15q, as well. Recently, a region in 15q22 has been shown to be altered in human myeloid leukemias (Roulston et al., 1998) , suggeting a role for DAPK2 in tumorigenesis.
In order to assess the biological functions of DAPK2, it is important to identify speci®c targets of DAPK2 that are phosphorylated during cell death or the upstream molecules that regulate the activity of DAPK2. To date, the speci®c targets for DAP-, ZIPkinases and DRAKs or the upstream regulators have not yet been identi®ed. Study of cellular localization may provide some insight to the identi®cation of such molecules. Members of DAP kinase family are known to dier in their intracellular localizations. DAPK2 was localized in the cytoplasm. DAP kinase was reported to be closely associated with cytoskeleton through the region located at the downstream to the ankyrin repeats (Figure 1f ). On the other hand, ZIP kinase, DRAK1 and DRAK2 were reported to be localized to the nuclei Sanjo et al., 1998) . These observations suggest a dierent substrate speci®city or dierent activation mechanisms among the DAP kinase family. One possible in vivo target of DAPK2 is MLC. Recently, it has been demonstrated that MLC phosphorylation was increased in cells undergoing apoptotic membrane blebbing and that MLC phosphorylation was blocked by inhibitors of MLCK. Furthermore, the MLCK inhibitor ML-9 blocked membrane blebbing induced by serum deprivation, and decreased MLC phosphorylation (Mills et al., 1998) . These results suggest that the DAP kinase family may play a key role in these observations.
The functional role of DAPK2 in apoptotic signaling remains to be clari®ed. Determination of the autophosphorylation site is one way to elucidate the activation mechanism and the biochemical functions of DAPK2. It is also important to understand whether DAPK2 is activated by apoptotic stimuli such as TNF-a, Fas, IFNg, DNA-damage and stresses. Furthermore, the use of caspase inhibitors may clarify the relationship between DAPK2-induced apoptosis and the caspase activation. We examined the eect of the caspase inhibitor such as Z-VAD-fmk on DAPK2-induced apoptosis. We overexpressed DAPK2 WT or DCaM into 293 and NIH3T3 cells that had been pretreated with this inhibitor, and the ratio of the apoptotic cells were measured by X-Gal staining. In these cells, however, treatment with this peptide did not aect the ability of DAPK2 to induce apoptosis (our unpublished data), suggesting that DAPK2-induced apotosis is independent of the caspase activation or DAPK2 functions downstream to the caspases. Recently, it has been reported that several types of apoptosis are not inhibited by the caspase inhibitors (Xiang et al., 1996; Miller et al., 1997; Lavoie et al., 1998; Quignon et al., 1998) . DAPK2-induced cell death may contribute with these pathways. To better understand these subjects, we are currently investigating the signaling pathway mediated by DAPK2.
Materials and methods
Materials
Ca
2+
-Ionophore A23187 and Ionomycin were purchased from Sigma. Thapsigargin was purchased from Calbiochem.
cDNA cloning
The Expression Sequence Tags (EST) clones were identi®ed by the BLAST program with the nucleotide sequence of the catalytic domain of DAP kinase as the query. Two EST clones (GenBank accession numbers; AA858002, W82116) showed signi®cant homology to DAP kinase. Full length cDNA was obtained using the RACE protocol from human skeletal muscle and mouse lung cDNA libraries according to the manufacturer's instructions (Marathon cDNA amplification kit; Clontech). The primer sequence was made available upon request.
Northern blot analysis
Full length cDNA of human DAPK2 was used to probe human Multiple Tissue Northern blots containing 2 mg of poly (A) + RNA isolated from various tissues according to the manufacture's instructions (Clontech).
Cells and cell culture
Monkey COS-7, human 293 and murine NIH3T3 cells were cultured in Dulbecco's Modi®ed Eagle Medium (DMEM) (Gibco BRL) supplemented with 10% fetal bovine serum (Gibco BRL) in the presence of 5% CO 2 at 378C.
Plasmids N-terminal Flag-tagged human DAPK2 was obtained by PCR and ligated into a mammalian expression vector pEF-BOS . To construct DAPK2 K52A and DAPK2 DCaM mutant, site-directed mutagenesis was performed using a site-directed mutagenesis kit according to the manufacturer's instructions (Clontech). Sequence of the primer was available upon request.
In vitro kinase assay and Western blot analysis
One million 293 cells were transiently transfected with the plasmids by Lipofection according to the manufacturer's instructions (Mirus Co.). Twenty-four hours after transfection, cells were lysed in the lysis buer containing 10 mM Tris-Cl (pH 7.4), 1.0% Triton X-100, 150 mM NaCl and 1 m EDTA. The cell lysates were immunoprecipitated with antiFlag M2 antibody (Sigma) as described previously . In vitro kinase reaction was carried out in 20 ml of the kinase buer containing 10 mCi [g-32 P]ATP, 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 3 mM MnCl 2 , 1 mM CaM (Calbiochem) and 0.5 mM CaCl 2 or 3 mM EGTA in the presence of 3.0 mg of MLC (Sigma) for 30 min at 308C. The reaction was terminated by adding Laemmli sample buer, and proteins bound to the beads were eluted by boiling. Proteins were separated on SDS ± PAGE and visualized by autoradiography.
For Western blot analysis, the cell lysates were dissolved by SDS ± PAGE, and transferred onto a nitrocellulose membrane. The membrane was blocked, then incubated with anti-Flag antibody. The membrane was then reacted with peroxidase labeled anti-mouse Ig antibody. After extensive washing, peroxidase activity was detected by using the enhanced chemiluminescence system (NEN).
Calmodulin overlay assay
COS-7 cells transiently transfected with the indicated plasmids were lysed in the buer containing 10 mM Tris-Cl (pH 7.4), 0.5% Nonidet P-40, 150 mM NaCl and 1 mM EDTA. The whole cell lysates were dissolved by SDS ± PAGE and transferred onto a nitrocellulose membrane. The ®lter was pre-incubated in CaM-binding buer (50 mM TrisCl pH 7.5, 150 mM NaCl, 1 mM CaCl 2 and 3.0% skim-milk) for 1 h. The membrane was then incubated with biotinylatedCaM (Calbiochem) in the CaM-binding buer for 12 h at room temperature, and washed three times in CaM-binding buer. The membrane was further reacted with Avidinperoxidase (Bio-Rad) for 1 h. After washing ®ve times, peroxidase activity was detected by using the enhanced chemiluminescence system. The same lysates were subjected to the Western blot analysis with anti-Flag antibody. 3610 5 ) were transiently cotransfected with 3.0 mg of the DAPK2 construct along with 0.3 mg of LacZ expression plasmid (pEF-BOS LacZ) as an indicator of transfection. After 36 h, transfected cells were visualized by X-Gal staining as described previously . (5610 4 ) grown on the cover slip were transiently transfected with 1.0 mg of the plasmid. After 24 h, cells were ®xed and doubly stained with anti-Flag antibody and DAPI (Wako) as described previously .
X-Gal staining of cells
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Cellular localization of Flag-DAPK2 protein
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Interspeci®c mouse backcross mapping
Interspeci®c backcross progeny were generated by mating (C57BL/6J x M. spretus) F1 females and C57BL/6J males as described (Copeland and Jenkins, 1991) . A total of 205 N 2 mice were used to map the DAPK2 locus (see text for details). DNA isolation, restriction enzyme digestion, agarose gel electrophoresis, Southern blot transfer and hybridization were performed essentially as described (Jenkins et al., 1982) . All blots were prepared with Hybond-N + nylon membrane (Amersham). The probe, an *300 bp BamHI/ XbaI fragment from the 3'UTR of the mouse cDNA, was labeled with a 32 P-dCTP using a random primed labeling kit (Stratagene); washing was done to a ®nal stringency of 1.06SSCP, 0.1% SDS, 658C. A fragment of 6.5 kb was detected in HindIII digested C57BL/6J DNA and a fragment of 9.1 kb was detected in HindIII digested M spretus DNA. The presence or absence of the 9.1 kb HindIII M. spretusspeci®c fragment was followed in backcross mice.
A description of the probes and RFLPs for the loci linked to DAPK2 including Atm, Csk and Rora has been reported previously (Giguere et al., 1995; Pecker et al., 1996) . Recombination distances were calculated using Map Man-ager, version 2.6.5. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.
Accession numbers
The nucleotide sequence data reported in this paper will appear in the DDBJ, EMBL and GenBank nucleotide sequence databases with accession numbers AB018001 (human DAPK2) and AB018002 (mouse DAPK2).
